Results for tag: "Betrixaban Testing"

Betrixaban testing is a diagnostic tool used to detect the presence of betrixaban, a direct factor Xa inhibitor anticoagulant. Betrixaban is used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Betrixaban testing is used to monitor the levels of betrixaban in the blood, as well as to assess the effectiveness of the drug. The test is typically performed using a point-of-care device, such as a handheld analyzer, and is used to measure the concentration of betrixaban in the blood. The Betrixaban testing market is a rapidly growing segment of the diagnostics industry, driven by the increasing prevalence of non-valvular atrial fibrillation and the need for effective anticoagulant therapy. The market is expected to continue to grow in the coming years, as more patients are prescribed betrixaban and the need for accurate and reliable testing increases. Some of the major companies in the Betrixaban testing market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, and Alere. Show Less Read more